Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis–associated interstitial lung disease are not predictive of disease progression-Reference-Cited by-同舟云学术

Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis–associated interstitial lung disease are not predictive of disease progression

Published:2007 Issue:6 Volume:56 Page:2005-2012
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Goh Nicole S. L.,Veeraraghavan Srihari,Desai Sujal R.,Cramer Derek,Hansell David M.,Denton Christopher P.,Black Carol M.,du Bois Roland M.,Wells Athol U.

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference31 articles.

1. Cyclophosphamide versus Placebo in Scleroderma Lung Disease

2. Cyclophosphamide Is Associated with Pulmonary Function and Survival Benefit in Patients with Scleroderma and Alveolitis

3. Evaluation and management of scleroderma lung disease using bronchoalveolar lavage

4. Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung.

5. Pulmonary involvement in diffuse cutaneous systemic sclerosis: broncheoalveolar fluid granulocytosis predicts progression of fibrosing alveolitis

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interstitial Lung Disease Associated with Systemic Sclerosis;Seminars in Respiratory and Critical Care Medicine;2024-05-07

2. Treatment of Interstitial Lung Disease in Systemic Sclerosis;Scleroderma;2024

3. Clinical Assessment of ILD;Scleroderma;2024

4. Overview of Lung Involvement;Scleroderma;2024

5. Heterogeneity of determining disease severity, clinical course and outcomes in systemic sclerosis-associated interstitial lung disease: a systematic literature review;RMD Open;2023-11